Generic Name and Formulations:
Nicotine polacrilex 2mg, 4mg; chewing gum; sugar-free; contains sodium, calcium; mint, fresh mint, white ice mint, cinnamon surge, fruit chill, or original flavor.
Indications for NICORETTE:
Adjunct in smoking cessation therapy.
Start on quit day. Use 2mg if patient smoked first cigarette >30 mins after waking up; use 4mg if patient smoked first cigarette within 30 mins of waking up. Chew gum slowly until it tingles; park between cheek and gum; repeat until most of the tingle is gone (about 30 mins). ≥18yrs: Use 1 piece every 1–2hrs for 6 weeks (at least 9 pieces/day), then every 2–4hrs for 3 weeks, then every 4–8hrs for 3 weeks, then stop; max 24 pieces/day. If strong or frequent cravings, may use 2nd piece within the hour; avoid continuous use.
<18yrs: not recommended.
Cardiovascular disease, recent heart attack, irregular heart beat. Uncontrolled hypertension. Peptic ulcer disease. Diabetes. History of seizures. Sodium-restricted diet. Discontinue and evaluate if irregular heart beat, palpitations, mouth/teeth/jaw problems, persistent indigestion, severe sore throat, nicotine overdose symptoms, or allergic reactions occur. Keep out of reach of children and pets. Pregnancy. Nursing mothers.
Do not eat or drink for 15 mins before and during use. Concomitant other non-nicotine smoking cessation drug. Concomitant antidepressants or anti-asthmatic drugs; may need to adjust dose.
Nausea, vomiting, diarrhea, hiccups, heartburn, dizziness, palpitations, hypertension, mouth problems.
Gum—20, 100, 110, 200; Lozenge—(mint, cherry)—72; (original)—108; Mini lozenge—20, 81, 108, 135
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies